Andexanet alfa therapy showed No increased rate of thromboembolic events in spontaneous intracranial hemorrhage patients: A multicenter electronic health record study.

Autor: Vellek J; School of Medicine, New York Medical College, Valhalla, NY, 10595, United States., Tarawneh OH; School of Medicine, New York Medical College, Valhalla, NY, 10595, United States., Kazim SF; Department of Neurosurgery, University of New Mexico Hospital (UNMH), Albuquerque, NM, 87131, United States., Owodunni OP; Department of Neurosurgery, University of New Mexico Hospital (UNMH), Albuquerque, NM, 87131, United States., Arbuiso S; School of Medicine, New York Medical College, Valhalla, NY, 10595, United States., Shah S; PRISMA Health Richland/University of South Carolina School of Medicine, 1 Medical Park, Suite 230, Columbia, SC, 29203, United States., Dicpinigaitis AJ; School of Medicine, New York Medical College, Valhalla, NY, 10595, United States., Schmidt MH; Department of Neurosurgery, University of New Mexico Hospital (UNMH), Albuquerque, NM, 87131, United States., McKee RG; Department of Surgery, University of New Mexico, Albuquerque, NM, 87106, United States., Miskimins R; Department of Surgery, University of New Mexico, Albuquerque, NM, 87106, United States., Al-Mufti F; Department of Neurosurgery, Westchester Medical Center/New York Medical College, Valhalla, NY, 10595, United States., Bowers CA; Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Sandy, UT, United States.
Jazyk: angličtina
Zdroj: World neurosurgery: X [World Neurosurg X] 2024 Mar 27; Vol. 23, pp. 100367. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
DOI: 10.1016/j.wnsx.2024.100367
Abstrakt: •Intracranial hemorrhage accounts for two out of every three major intracranial hemorrhages.•Systemic anticoagulation is routinely prescribed for prevention of cerebrovascular accidents.•The FDA approved Andexanet alfa to treat life-threatening bleeding.•Andexanet alfa relationship to outcomes requires further investigation.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2024 The Authors.)
Databáze: MEDLINE